Greenwich LifeSciences
GLSI
$13.98
Share price
-3.25%
Change (1 day)
19.08%
Change (1 year)
Categories
Earnings for Greenwich LifeSciences (GLSI)
Earnings in 2023 (TTM): -$9.39 M
According to Greenwich LifeSciences's latest financial reports the company's current earnings (TTM) are -$9.33 M. In 2022 the company made an earning of -$8.05 M a decrease over its 2021 earnings that were of -$4.6 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Greenwich LifeSciences from 2020 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$9.39 M | 16.74% |
| 2022 | -$8.05 M | 74.87% |
| 2021 | -$4.6 M | 146.7% |
| 2020 | -$1.87 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -$19.09 M | 104.58% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -$73.07 M | 683.25% | 🇬🇧 UK |
 Novavax NVAX | -$0.53 B | 5,567.05% | 🇺🇸 USA |
 Novocure
NVCR | -$0.17 B | 1,719.19% | Jersey |